Antibodies to GD3, GT3, and O-acetylated species in Guillain-Barré and Fisher′s syndromes: Their association with cranial nerve dysfunction (original) (raw)

Mechanisms of Action of Anti‐GM1and Anti‐GQ1bGanglioside Antibodies in Guillain‐Barré Syndrome

Hugh Willison

The Journal of Infectious Diseases, 1997

View PDFchevron_right

Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a

Satoshi Kuwabara

Journal of Neuroimmunology, 2006

View PDFchevron_right

Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay

Carla D'Avino

Journal of the Neurological Sciences, 2002

View PDFchevron_right

Prospective study on anti-ganglioside antibodies in childhood Guillain-Barre syndrome

Janbernd Kirschner

Archives of Disease in Childhood, 2007

View PDFchevron_right

Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides

Cándido Juárez

Annals of Neurology, 1995

View PDFchevron_right

Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome

Nina M van Sorge

Autoimmunity Reviews, 2004

View PDFchevron_right

Clinical presentation and outcome of Guillain–Barré and related syndromes in relation to anti-ganglioside antibodies

Guido Cavaletti

Journal of The Neurological Sciences, 1999

View PDFchevron_right

Ganglioside Molecular Mimicry and Its Pathological Roles in Guillain-Barre Syndrome and Related Diseases

Toshio Ariga

Infection and Immunity, 2006

View PDFchevron_right

Anti‐ganglioside antibodies and elevated CSF IgG levels in Guillain‐Barré syndrome

A. Amantini

European Journal of Neurology, 2006

View PDFchevron_right

Antiganglioside antibodies are associated with axonal Guillain-Barré syndrome: A Japanese-Italian collaborative study

Satoshi Kuwabara

Journal of Neurology, Neurosurgery and Psychiatry, 2012

View PDFchevron_right

Electrophysiological assessment of Guillain-Barré syndrome with both Gal-C and ganglioside antibodies; tendency for demyelinating type

Makoto Samukawa

Journal of Neuroimmunology, 2016

View PDFchevron_right

Antiganglioside antibodies and their pathophysiological effects on Guillain-Barre syndrome and related disorders--A review

Toshio Ariga

Glycobiology, 2009

View PDFchevron_right

Prominent sensory ataxia in Guillain–Barré syndrome associated with IgG anti-GD1b antibody

Gustav Pfeiffer

Journal of the Neurological Sciences, 1997

View PDFchevron_right

Anti-GD1a ganglioside antibodies in peripheral motor syndromes

Sergio Barbieri

Annals of Neurology, 1996

View PDFchevron_right

Antibodies to Ganglioside Complexes in Guillain-Barré Syndrome: Clinical Correlates, Fine Specificity and Complement Activation

Antonino Uncini

International Journal of Immunopathology and Pharmacology, 2009

View PDFchevron_right

Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies

Eduardo Nobile-orazio

Journal of the Neurological Sciences, 1992

View PDFchevron_right

Antibodies to GM1(NeuGc) in Guillain–Barré syndrome after ganglioside therapy

Eduardo Nobile-orazio

Journal of the Neurological Sciences, 2000

View PDFchevron_right

Assessment of Anti-Ganglioside Antibodies in Patients Diagnosed With Guillain Barre Syndrome

Hikmat Ullah

Pakistan Armed Forces Medical Journal, 2022

View PDFchevron_right

Comparison of immunoblotting and ELISA for detection of anti-ganglioside antibodies in children with Guillain-Barre syndrome

Mojtaba Barzegar, M. Hashemilar, Reza Badalzadeh

Iranian journal of …, 2010

View PDFchevron_right

Neurophysiological and immunohistochemical studies on Guillain-Barré syndrome with IgG anti-GalNAc-GD1a antibodies—effects on neuromuscular transmission

Toshio Ariga

Journal of the Neurological Sciences, 2004

View PDFchevron_right

Antibodies to single glycolipids and glycolipid complexes in Guillain-Barre syndrome subtypes

Satoshi Kuwabara

Neurology, 2014

View PDFchevron_right

Neuropathophysiological potential of Guillain-Barré syndrome anti-ganglioside-complex antibodies at mouse motor nerve terminals

Hugh Willison

Clinical and Experimental Neuroimmunology, 2011

View PDFchevron_right

Axonal Guillain-Barré syndrome: concepts and controversies

Satoshi Kuwabara

The Lancet Neurology, 2013

View PDFchevron_right

Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barre syndrome

Satoshi Kuwabara

Neurology, 2005

View PDFchevron_right

Range of cross reactivity of anti-GM1 IgG antibody in Guillain-Barre syndrome

Michiaki Koga

Journal of Neurology, Neurosurgery & Psychiatry, 2001

View PDFchevron_right

Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barr� syndrome

Arthur K Asbury

Annals of Neurology, 1999

View PDFchevron_right

Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain–Barré syndrome

Pamela McCombe

Journal of Clinical Neuroscience, 2005

View PDFchevron_right

Ganglioside-specific IgG and IgA recruit leukocyte effector functions in Guillain–Barré syndrome

Nina M van Sorge

Journal of Neuroimmunology, 2007

View PDFchevron_right

Anti-ganglioside complex antibody profiles in a recurrent complicated case of GQ1b-seronegative miller fisher syndrome and Bickerstaff brainstem encephalitis: a case report

Yuki Fukami

BMC Neurology

View PDFchevron_right

Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside

Gordon Paterson

Journal of Neurology Neurosurgery and Psychiatry, 1993

View PDFchevron_right

Anti-GM1 IgG antibodies in Guillain–Barré syndrome: fine specificity is associated with disease severity

Ricardo D Lardone

Journal of Neurology Neurosurgery and Psychiatry, 2010

View PDFchevron_right

Axonal Guillain-Barré syndrome: a critical review

amit arora

Acta Neurologica Scandinavica, 2001

View PDFchevron_right

Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neurons and motor nerves

Toshio Ariga

Brain Research, 2008

View PDFchevron_right